Literature DB >> 1262460

Clearance and acid-stimulating action of human big and little gastrins in duodenal ulcer subjects.

J H Walsh, J I Isenberg, J Ansfield, V Maxwell.   

Abstract

Acid-stimulating action and clearance of pure natural human big gastriin (HG-34-I) and little gastrin (HG-17-I) were assessed in four male subjects with inactive duodenal ulcer (DU) disease. Disappearance half-times for HG-17-I after intravenous infusion (5.2 min) or rapid intravenous injection (6.4 min) were six to eight times shorter than those for HG-34-I (41.5 and 37.8 min, respectively). Studies of clearance of synthetic human little gastrin (HG-17-I) were performed in three of these same four DU subjects, eight additional male DU subjects, and eleven normal male subjects. The disappearance halftime of synthetic HG-17-I averaged 6.2 min in both the DU subjects and the normal subjects. These data suggest that clearance of exogenous gastrin is not altered in patients with DU. Acid secretion in response to rapid intravenous injection of HG-34-I reached a higher peak and lasted longer than in response to an equimolar dose of HG-17-I; the total response to HG-34-I was about three times that to HG-17-I. During constant intravenous infusion, acid responses to equimolar exogenous doses of the two peptides were similar but the increment in molar concentration of circulating gastrin was six to eight times greater with HG-34-I than with HG-17-I. Chromatography of serum obtained during infusions of HG-34-I revealed no evidence of conversion to HG-17-I, nor was there any increase in circulating G-34 activity during infusions of HG-17-I. The increment in serum gastrin concentration required to produce half-maximal stimulation of gastric acid secretion (D50) was estimated in each subject for each gastrin from curves relating acid secretion to change in serum gastrin concentration produced by infusion of these peptides. After instilling peptone solution into the stomach, acid secretion was measured by intragastric titration, and increases in circulating G-17 and G-34 were determined by chromatography and radioimmunoassay of serum. Increases in circulating G-17 and G-34 in response to the peptone meal, taken together, were equivalent to 1.5 times the D50 determined from infusions of G-34 and G-17. Acid secretion during the same time period averaged 55% of maximal rates. Although G-34 comprised approximately three-fourths of the total molar concentration of circulating gastrin after stimulation, it was estimated to contribute less than half of the acid-stimulating activity.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1262460      PMCID: PMC436764          DOI: 10.1172/JCI108379

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  13 in total

1.  Increased sensitivity to stimulation of acid secretion by pentagastrin in duodenal ulcer.

Authors:  J I Isenberg; M I Grossman; V Maxwell; J H Walsh
Journal:  J Clin Invest       Date:  1975-02       Impact factor: 14.808

Review 2.  The Bayliss-Starling lecture 1973. The gastrointestinal hormones: a review of recent advances.

Authors:  R A Gregory
Journal:  J Physiol       Date:  1974-08       Impact factor: 5.182

3.  Studies on the distribution and degradation of heptadecapeptide, big, and big big gastrin.

Authors:  E Straus; R S Yalow
Journal:  Gastroenterology       Date:  1974-05       Impact factor: 22.682

4.  Additional studies on the nature of big big gastrin.

Authors:  R S Yalow; N Wu
Journal:  Gastroenterology       Date:  1973-07       Impact factor: 22.682

5.  Metiamide, an H2-receptor blocker, as inhibitor of basal and meal-stimulated gastric acid secretion in patients with duodenal ulcer.

Authors:  M Mainardi; V Maxwell; R A Sturdevant; J I Isenberg
Journal:  N Engl J Med       Date:  1974-08-22       Impact factor: 91.245

6.  Amino terminal gastrin fragment in serum of Zollinger-Ellison syndrome patients.

Authors:  G J Dockray; J H Walsh
Journal:  Gastroenterology       Date:  1975-02       Impact factor: 22.682

7.  Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer.

Authors:  J S Fordtran; J H Walsh
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

8.  Metabolic clearance and disappearance rates of synthetic human gastrin in man.

Authors:  E Schrumpf; L S Semb; H Vold
Journal:  Scand J Gastroenterol       Date:  1973       Impact factor: 2.423

9.  Pure human big gastrin. Immunochemical properties, disappearance half time, and acid-stimulating action in dogs.

Authors:  J H Walsh; H T Debas; M I Grossman
Journal:  J Clin Invest       Date:  1974-08       Impact factor: 14.808

10.  Immunoreactive gastrin components in human serum.

Authors:  J F Rehfeld; F Stadil; J Vikelsoe
Journal:  Gut       Date:  1974-02       Impact factor: 23.059

View more
  26 in total

1.  Measurement of secretory vesicle pH reveals intravesicular alkalinization by vesicular monoamine transporter type 2 resulting in inhibition of prohormone cleavage.

Authors:  C G Blackmore; A Varro; R Dimaline; L Bishop; D V Gallacher; G J Dockray
Journal:  J Physiol       Date:  2001-03-15       Impact factor: 5.182

Review 2.  The endoproteolytic maturation of progastrin and procholecystokinin.

Authors:  Jens F Rehfeld
Journal:  J Mol Med (Berl)       Date:  2006-05-06       Impact factor: 4.599

Review 3.  Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones.

Authors:  Amosy E M'Koma; Paul E Wise; Roberta L Muldoon; David A Schwartz; Mary K Washington; Alan J Herline
Journal:  Int J Colorectal Dis       Date:  2007-06-19       Impact factor: 2.571

4.  Duodenal gastrin concentration in upper gastrointestinal disorders.

Authors:  W S Hughes
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

5.  Pathways of processing of the gastrin precursor in rat antral mucosa.

Authors:  A Varro; S Voronina; G J Dockray
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  Role of gastrin heptadecapeptide in the acid secretory response to amino acids in man.

Authors:  M Feldman; J H Walsh; H C Wong; C T Richardson
Journal:  J Clin Invest       Date:  1978-02       Impact factor: 14.808

7.  Similar acid stimulatory potencies of synthetic human big and little gastrins in man.

Authors:  V E Eysselein; V Maxwell; T Reedy; E Wünsch; J H Walsh
Journal:  J Clin Invest       Date:  1984-05       Impact factor: 14.808

8.  Sex-related differences in gastrin release and parietal cell sensitivity to gastrin in healthy human beings.

Authors:  M Feldman; C T Richardson; J H Walsh
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

9.  Stimulation of gastrin secretion and synthesis in antral organ culture.

Authors:  R F Harty; J C van der Vijver; J E McGuigan
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

10.  Origin of gastrin liberated by gastrin releasing peptide in man.

Authors:  L Lundell; G Lindstedt; L Olbe
Journal:  Gut       Date:  1987-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.